Comparative efficacy and safety of fexuprazan versus esomeprazole in gastroesophageal reflux disease: a systematic review and meta-analysis. (PubMed, Front Med (Lausanne)) - May 26, 2026 - "No statistically significant difference in the incidence of TEAEs or ADRs was observed between treatments, suggesting a comparable safety profile. https://www.crd.york.ac.uk/PROSPERO/view/CRD420261286108."
Journal • Retrospective data • Review • Gastroenterology • Gastroesophageal Reflux Disease
|
|
Abdullah Abureesh; Ahmad Abdulraheem; Ahmad Abou Yassine; Ali Sohail; Jean Chalhoub; Nadera Altork; Omar Abureesh; Ryan Tam; Sherif Andrawes; Uday Sankar Akash Vankayala; Yousef Yousef; Youssef El Douaihy
|